• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

极光 B:癌症的一个新预后标志物和治疗靶点。

Aurora B: a new prognostic marker and therapeutic target in cancer.

机构信息

Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli Federico II, via Pansini, 5 (80131) Naples, Italy.

出版信息

Curr Med Chem. 2011;18(4):482-96. doi: 10.2174/092986711794480203.

DOI:10.2174/092986711794480203
PMID:21143115
Abstract

Aurora B is a serine-threonine kinase belonging to the highly conserved Aurora family of mitotic kinases. Aurora B is a chromosomal passenger protein involved in chromosome segregation, spindle-checkpoint, and cytokinesis. Alteration of each of these steps could induce aneuploidy, one of main features, and driving force of cancer progression. The overexpression of Aurora B has been observed in several tumor types, and has been linked with a poor prognosis of cancer patients. In this review we will focus on the role of Aurora B in cancer development, its role as a prognostic marker, and the clinical outcome of recently developed Aurora(s) inhibitors.

摘要

极光 B 是一种丝氨酸-苏氨酸激酶,属于高度保守的有丝分裂激酶极光家族。极光 B 是一种染色体乘客蛋白,参与染色体分离、纺锤体检验点和胞质分裂。这些步骤中的任何一个改变都可能导致非整倍体,这是非整倍体的主要特征之一,也是癌症进展的驱动力。在几种肿瘤类型中观察到极光 B 的过表达,并与癌症患者的预后不良相关。在这篇综述中,我们将重点介绍极光 B 在癌症发展中的作用、作为预后标志物的作用,以及最近开发的极光(s)抑制剂的临床结果。

相似文献

1
Aurora B: a new prognostic marker and therapeutic target in cancer.极光 B:癌症的一个新预后标志物和治疗靶点。
Curr Med Chem. 2011;18(4):482-96. doi: 10.2174/092986711794480203.
2
Mitotic kinases: the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis.有丝分裂激酶:复制、分离、胞质分裂错误、染色体不稳定及肿瘤发生的关键因素。
Pharmacol Ther. 2006 Sep;111(3):974-84. doi: 10.1016/j.pharmthera.2006.02.006. Epub 2006 Apr 17.
3
Aurora-B kinase inhibitors for cancer chemotherapy.用于癌症化疗的极光激酶B抑制剂。
Mini Rev Med Chem. 2008 Dec;8(14):1514-25. doi: 10.2174/138955708786786480.
4
Targeting aurora kinases in cancer treatment.在癌症治疗中靶向极光激酶。
Curr Drug Targets. 2011 Dec;12(14):2067-78. doi: 10.2174/138945011798829410.
5
Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases.JNJ-7706621 抑制细胞周期蛋白依赖性激酶和 Aurora 激酶诱导的生长抑制和有丝分裂缺陷
Curr Cancer Drug Targets. 2012 Jul;12(6):625-39. doi: 10.2174/156800912801784839.
6
Clinical experience with aurora kinase inhibitors: a review.极光激酶抑制剂的临床经验:综述
Oncologist. 2009 Aug;14(8):780-93. doi: 10.1634/theoncologist.2009-0019. Epub 2009 Aug 14.
7
Shared and separate functions of polo-like kinases and aurora kinases in cancer.Polo-like 激酶和 Aurora 激酶在癌症中的共同和独立功能。
Nat Rev Cancer. 2010 Dec;10(12):825-41. doi: 10.1038/nrc2964. Epub 2010 Nov 24.
8
Phosphatase inhibitor-2 balances protein phosphatase 1 and aurora B kinase for chromosome segregation and cytokinesis in human retinal epithelial cells.磷酸酶抑制剂-2平衡蛋白磷酸酶1和极光B激酶,以实现人视网膜上皮细胞中的染色体分离和胞质分裂。
Mol Biol Cell. 2008 Nov;19(11):4852-62. doi: 10.1091/mbc.e08-05-0460. Epub 2008 Aug 20.
9
Aurora-C kinase supports mitotic progression in the absence of Aurora-B.在没有极光激酶B的情况下,极光激酶C支持有丝分裂进程。
Cell Cycle. 2009 Sep 15;8(18):2984-94. Epub 2009 Sep 21.
10
Aurora kinases in spindle assembly and chromosome segregation.极光激酶在纺锤体组装和染色体分离中的作用
Exp Cell Res. 2004 Nov 15;301(1):60-7. doi: 10.1016/j.yexcr.2004.08.016.

引用本文的文献

1
AURKB inhibition induces rhabdomyosarcoma apoptosis and ferroptosis through NPM1/SP1/ACSL5 axis.AURKB抑制通过NPM1/SP1/ACSL5轴诱导横纹肌肉瘤凋亡和铁死亡。
JCI Insight. 2025 Feb 10;10(3):e182429. doi: 10.1172/jci.insight.182429.
2
A single-cell atlas of the Culex tarsalis midgut during West Nile virus infection.西尼罗河病毒感染期间致倦库蚊中肠的单细胞图谱。
PLoS Pathog. 2025 Jan 27;21(1):e1012855. doi: 10.1371/journal.ppat.1012855. eCollection 2025 Jan.
3
Aurora kinase B inhibitor AZD1152: repurposing for treatment of lupus nephritis driven by the results of clinical trials.
极光激酶B抑制剂AZD1152:基于临床试验结果用于狼疮性肾炎治疗的重新定位
EBioMedicine. 2025 Feb;112:105553. doi: 10.1016/j.ebiom.2024.105553. Epub 2025 Jan 11.
4
A single-cell atlas of the midgut during West Nile virus infection.西尼罗河病毒感染期间中肠的单细胞图谱。
bioRxiv. 2024 Nov 24:2024.07.23.603613. doi: 10.1101/2024.07.23.603613.
5
A novel role of AURKA kinase in erythroblast enucleation.AURKA 激酶在红细胞去核中的新作用。
Haematologica. 2024 Nov 1;109(11):3721-3734. doi: 10.3324/haematol.2023.284873.
6
Coupling Kinesin Spindle Protein and Aurora B Inhibition with Apoptosis Induction Enhances Oral Cancer Cell Killing.将驱动蛋白纺锤体蛋白和Aurora B抑制与诱导凋亡相结合可增强口腔癌细胞杀伤作用。
Cancers (Basel). 2024 May 25;16(11):2014. doi: 10.3390/cancers16112014.
7
AURKB/CDC37 complex promotes clear cell renal cell carcinoma progression via phosphorylating MYC and constituting an AURKB/E2F1-positive feedforward loop.AURKB/CDC37 复合物通过磷酸化 MYC 并构成 AURKB/E2F1 正反馈环促进肾透明细胞癌的进展。
Cell Death Dis. 2024 Jun 18;15(6):427. doi: 10.1038/s41419-024-06827-y.
8
Pan-Cancer Analysis Reveals CENPI as a Potential Biomarker and Therapeutic Target in Adrenocortical Carcinoma.泛癌分析揭示CENPI作为肾上腺皮质癌的潜在生物标志物和治疗靶点。
J Inflamm Res. 2023 Jul 12;16:2907-2928. doi: 10.2147/JIR.S408358. eCollection 2023.
9
The structural basis of the multi-step allosteric activation of Aurora B kinase.Aurora B 激酶多步别构激活的结构基础。
Elife. 2023 May 25;12:e85328. doi: 10.7554/eLife.85328.
10
Aurora B Inhibitors as Cancer Therapeutics.极光 B 抑制剂作为癌症治疗药物。
Molecules. 2023 Apr 11;28(8):3385. doi: 10.3390/molecules28083385.